Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,716,102
+$248,957 QoQ
Shares Held
22,507
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,520
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL ADVISORS INC/OK holds $173,896,300 across 10 Drug Manufacturers - General names. JNJ ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
447,129 | $112,515,541 | |
| 2 | PFE |
Pfizer Inc
|
1,770,761 | $42,639,924 | |
| 3 | LLY |
ELI LILLY & Co
|
6,287 | $7,540,817 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
22,507 | $5,716,102 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,641 | $1,419,814 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,821 | $1,261,998 | |
| 7 | NVO |
Novo Nordisk A S
|
25,516 | $1,223,237 | |
| 8 | AMGN |
Amgen Inc
|
2,255 | $816,580 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,716,102 | 22,507 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,467,145 | 22,366 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,503,438 | 21,761 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,077,385 | 21,990 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,898,180 | 25,520 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,807,354 | 22,958 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,998,692 | 41,479 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7,971,407 | 49,188 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $7,372,895 | 50,444 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $10,568,199 | 66,807 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $46,949,586 | 299,538 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $45,839,094 | 294,312 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $45,312,258 | 273,757 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $40,268,225 | 259,795 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $41,141,255 | 232,897 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $36,963,630 | 226,271 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $15,884,837 | 89,487 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $16,214,418 | 91,488 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $15,713,634 | 91,855 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $14,559,386 | 90,151 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $14,859,218 | 90,198 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $14,768,326 | 89,859 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $14,094,795 | 89,559 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $12,647,058 | 84,948 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $11,573,989 | 82,301 | Shares | Sole | 2020-09-02 | |
| 2020-03-31 | $10,531,705 | 80,315 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||